Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with poor prognosis, early recurrence, and the lack of durable chemotherapy responses and specific targeted treatments. The recent FDA approval for immune checkpoint inhibition in combination with nab-paclitaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Adviti, Decock, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725706/
https://www.ncbi.nlm.nih.gov/pubmed/33324565
http://dx.doi.org/10.3389/fonc.2020.598626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725706/
https://www.ncbi.nlm.nih.gov/pubmed/33324565
http://dx.doi.org/10.3389/fonc.2020.598626

Ejemplares similares